Magnesium in type 2 diabetes mellitus and its correlation with glycemic control

Nehal Hamdy El-said, Noha Adly Sadik, Nagwa Abd EL-Ghaffar Mohammed


Background: Hypomagnesaemia may have negative impact on glucose homeostasis and insulin sensitivity. This study was done to compare serum Mg levels in type 2 diabetic patients with non diabetic healthy control subjects and to assess the correlation between serum Mg levels and glycemic control in Egyptian patients.

Methods: 60 type 2 diabetic patients attending the outpatient clinic of diabetes at Kasr Al Aini hospital faculty of medicine Cairo University and 30 healthy age matched control subjects were enrolled. Fasting blood sugar, fasting insulin, fasting lipids, Hb A1C and serum Mg were measured. Weight, height and blood pressure were recorded. BMI, IR (HOMA), were calculated. The data was analyzed and expressed in terms of mean ± SD. Pearson correlation was performed to establish the relationship between Mg and metabolic variables in type 2 diabetic patients.

Results: serum Mg levels were significantly reduced in type 2 diabetic patients compared to the control group with mean ±SD (1.29 ± 0.31 mg/dl) versus (2.41 ± 0.13 mg/dl) with P value < 0.001. There were highly significantly negative correlations between serum Mg levels and HbA1c, fasting glucose and insulin resistance with (r = -0.969, -0.894, -0.653) respectively, P value < 0.001. The best cut off point of Mg was ≤ 2.0 mg/dl in differentiating cases from controls using ROC curve analysis.

Conclusion: hypomagnesaemia is closely linked to type 2 diabetes mellitus and it is strongly correlated to glycemic control. We recommend to measure serum Mg in type 2 diabetes and patients who need supplementation should be considered.



Hypomagnesaemia, Type 2 diabetes mellitus, Glycemic control

Full Text:



Dharam P. Chaudhary & Rajeshwar Sharma & Devi D. Bansal. Implications of Magnesium Deficiency in Type 2 Diabetes: A Review. Biol Trace Elem Res. 2010;134:119–29.

Barbagallo M, Dominguez LJ. Magnesium and aging. Current Pharmaceutical Design. 2010;16:832–9.

Chhabra S, Chhabra S, Ramessur K, Chhabra N. Hypomagnesemia and its implications in Type 2 Diabetes Mellitus- A Review Article. Webmed Central Diabetes. 2012;3:WMC003878.

Mishra S, Padmanaban P, Deepti GN, Sarkar G, Sumathi S, Toora BD. Serum Magnesium and Dyslipidemia in Type-2 Diabetes Mellitus. Biomedical Res. 2012;23(2):295-300.

Saris NE, Mervaala E, Karppanen H, Khawaja JA, Le wenstam A. Magnesium: an update on physiological, clinical, and analytical aspects. Clinica Chimica Acta. 2000;294:1-26.

Supriya, Mohanty S, Pinnelli VB, Murgod R, Raghavendra DS. Evaluation of serum copper, magnesium and glycated haemoglobin in type 2 diabetes mellitus. Asian J Pharm Clin Res. 2013;6:188-90.

Badyal A, Sodhi KS, Pandey R, Singh J. Serum Magnesium Levels: A Key Issue For Diabetes Mellitus. JK Science. 2011;13:132-4.

Ankush RD, Suryakar AN and Ankush NR. Hypomagnesaemia in type-2 diabetes mellitus patients.A study on the status of oxidative and nitrosative stress. Indian J Clin Biochem. 2009;24:184-9.

Rude RK. Postgrad Med. 1992;92:217–24.

Hans CP, Sialy R, Bansal DD. Magnesium deficiency and diabetes mellitus. Curr Sci. 2002;83:1456-63.

Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension. 1993;21:1024-9.

Moles KW, McMullen JK. Insulin resistance and hypomagne-saemia. Br Med J. 1982;285:972.

Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, Pineo A, Busardo A, Paolisso G. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med. 2003;24:39-52.

Rasic-Milutinovic Z, Perunicic-Pekovic G, Pljexa S, Dangic A, Dangic A, ET AL. Magnesium deficiency in type 2 diabetes. Hippokratia. 2004;8:179-181.

Rodriguez-Moran M, Guerrero-Romero F. Elevated concentrations of TNF-alpha are related to low serum magnesium levels in obese subjects. Magnes Res. 2004;17:189–96.

Diabetes Association. Diabetes Care. 2012;35:S11-S65.

Maquart F, Giller P, Bernard J. Method for specifically measuring hemoglobin A1C with disposable ion exchange ion column. Clin Chem Acta. 1980;108:329.

Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.

Perez-Fontan M, Cordido F, Rodriguez-Carmona A, Peteiro J, Garcia-Naveiro R, Garcia-Buela J. Plasma ghrelin in patients undergoing haemodialysis and peritoneal dialysis. Nephrol Dial Transplant. 2004;19(8):2095-100.

Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modelling. 2004;27:1487-95.

Ramasamy R, Murugalyan SB, Gopal N, Shalini R. The prospect of serum magnesium and an electrolyte panel as an adjuvant cardiac biomarker in the management of acute myocardial infarction. Journal of Clinical and Diagnostic Research. 2013;7(5):817-20.

Wälti MK, Zimmermann MB, Spinas GA, Hurrell RF. Low plasma magnesium in type 2 diabetes. Swiss Med Wkly. 2003;133:289–92.

Naila M, Hussain BG, Ahmed GR, Ahmed MI, Muhammad A, Sadik MM. Serum Zinc and Magnesium in Type 2 Diabetic patients. J Coll Physicians Surg Pak. 2009;19:483-6.

Zargar AH, Shah NA, Masoodi SR, Laway BA, Dar FA, Khan AR, et al. Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus. Postgrad Med J. 1998;74(877):665–68.

Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. American Diabetes Association. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care. 2005;28:956–62.

Quamme GA. Renal handling of magnesium. In: Massry and Glassock’s Textbook of Nephrology, 4th Ed., edited by Massry SH, Glassock RJ, Baltimore, Lippincott Williams &Wilkins, 2001; 344–350.

Dai LJ, Friedman PA, Quamme GA. Cellular mechanisms of chlorothiazide and potassium depletion on Mg2_ uptake in mouse distal convoluted tubule cells. Kidney Int. 1997;51:1008-17.

Dai LJ, Friedman PA, Quamme GA. Acid-base changes alter Mg2_ uptake in mouse distal convoluted tubule cells. Am J Physiol Renal Physiol. 1997;272: F759–66.

Hodler J, Roulin F, Haldimann B. Short-term effect of thiazides on magnesium and calcium metabolism and secondarily on that of phosphorus, uric acid, oxalate and cyclic AMP [in French]. Nephrologie. 1983;4:60–3.

Karim R, Nargis, KA Begum, SS Subhan, Uddin MN. Bangladesh J Med Biochem. 2014;7:4-8.

Seedahmed TAE, Ahmed SM. Correlation between the Plasma Magnesium Levels and Glycated Haemoglobin in Sudanese Patients with Type 2 Diabetes Mellitus in Khartoum State. Advances in Diabetes and Metabolism. 2013;1:1-5.

Mamatha BV, Shankarprasad DS, Manjula R. A comparative study of serum magnesium in type 2 diabetes mellitus patients and non diabetics and its correlation with glycemic status. Int J Bioassays. 2014;3:3395-8.

de Valk HW. Hypomagnesaemia and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35:904-5.

Vanroelen WF, Van Gaal LF, Van Rooy PE, De Leeuw IH. Serum and erythrocyte magnesium levels in type I and type II diabetics. Acta Diabetol Lat. 1985;22:185–90.

Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPICNorfolk). BMJ. 2001;322:15-8.

Hamid Nasri H, Baradaran HR. Lipid in association with serum magnesium in diabetes mellitus patients. Bartisl Lek Listy. 2008;109:302-6.

Corica F, Allegra A, Di Benedeto A, et al . Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. Magnes Res. 1994;7:43-7.

Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003;26:1147-52.

Solati M, Ouspid E, Hosseini S, Soltani N, Keshavarz M, Dehghani M. Oral magnesium supplementation in type II diabetic patients. MJIRI. 2014;28:1-8.